Paragon Biomedical is a full-service, woman-owned clinical research organization (CRO) providing Phase I - IV clinical trial support to the world’s pharmaceutical, biotechnology, and medical device companies. For over 20 years our insights, processes, and infrastructure have helped clients maximize their research resources in major therapeutic areas, including:
|
|
Clients benefit from our status as a privately-held CRO (also known as a contract research organization) because we have the autonomy to create the comprehensive clinical trial management strategies needed to achieve their objectives. And with offices in the United States, the United Kingdom, and India, we have trained, experienced research professionals working from the geographic regions that are central to our clients’ objectives.
Low turnover rates (16% in 2009) create important benefits for our clients, including:
Our proven ability to compete (and win) against large CROs means we know how to leverage our experience, size, and culture in ways that provide efficient, cost-effective solutions. Genuine executive participation is rare among global CROs; however, our clients appreciate the value of their contributions.
Paragon is one of the only woman-owned CROs certified by the National Women Business Owners Corporation (NWBOC) and the Women's Business Enterprise National Council (WBENC) as a woman-owned business. Our certification often benefits our clients’ own diversity initiatives.
Clients planning trials find that having a “sales-neutral” conversation with our operational and medical experts helps them make informed, confident decisions. To speak with one of Paragon’s experts, contact us today.
![]() |
Subscribe |
Login/Register — Please click here to submit or update an investigator profile.